Revolution Medicines

Area Business Director, Lung, Prairie

Remote (United States) · Director · Full-time

Sponsorship not specified$12k-$15kDetected 22 hours ago

ComplianceProject ManagementSalesExcelResearchLeadershipCommunicationCollaborationMentoringMicrosoft Office

About the role

The Area Business Director is responsible for the team promoting Revolution Medicines products/services to the oncology community in the Prairie area.
In addition, they are responsible for growing several key business relationships with Area-Level healthcare accounts, including major health systems, large practice networks, and Area specific GPOs.
The states covered in this geography are: Illinois, Iowa, Minnesota, South Dakota, North Dakota, Nebraska, Missouri (partial), Indiana (partial).

Utilizes sales data and analytics to build launch plans, identify growth opportunities, inform strategic decisions and contribute to quarterly business reviews.
Recruits and develops a best-in-class sales team, cultivates a culture of exceptional performance, accountability and patient first mentality.
Designs and implements Area-specific sales strategies that align with brand objectives leveraging deep market insights and customer needs.
Drives exceptional team performance by setting clear goals, providing tailored coaching and recognizing and rewarding successful behaviors.
Leads the development and alignment to key levers of performance such as quarterly business plans and skill building to ensure top performance.
Manages all resources within budget.
Develops top talent, by encouraging growth and providing opportunities for exposure.

BA/BS degree and 12-15 years of biopharma industry experience.
Proven track record of success leading product launches ideally in NSCLC oncology therapeutic space.
Experience launching oncology products with companion diagnostics.
Proven performer in highly competitive marketplaces.
Ability to travel to meetings/training/programs, as necessary.
Experience in small to midsize biotech space.
Proven effectiveness in highly collaborative & cross-functional working environments.
Valid driver's license.
~50% travel required.
MA/MS degree preferred.
Experience in the NSCLC oncology space.

$245,000 - $290,000 USD
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.

Creates and communicates short and long-term vision, strategies and initiatives in alignment with corporate goals and objectives.
Acts as a conduit for relevant market information from local, field-based employees to home office leadership, as well as appropriate recommendations for action.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.